Technical Analysis for OVID - Ovid Therapeutics Inc.

Grade Last Price % Change Price Change
grade D 2.31 -3.35% -0.08
OVID closed down 3.35 percent on Friday, October 18, 2019, on 28 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Down
See historical OVID trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -3.35%
NR7 Range Contraction -3.35%
Wide Bands Range Expansion -3.35%
Oversold Stochastic Weakness -3.35%
Narrow Range Bar Range Contraction -2.53%
Wide Bands Range Expansion -2.53%
Oversold Stochastic Weakness -2.53%
Narrow Range Bar Range Contraction -3.35%

Older signals for OVID ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Ovid Therapeutics Inc. (Ovid) is a biopharmaceutical company. The Company is engaged in developing medicines for patients and families living with rare neurological disorders. Its lead drug candidate is OV101. The Company’s second lead drug candidate is OV935. OV101 (gaboxadol) is a delta-selective GABAA receptor agonist. Ovid is developing OV101 for use in both Angelman syndrome and Fragile X syndrome to potentially restore tonic inhibition and relieve several of the symptoms of these disorders. Ovid has initiated the Phase II STARS trial of OV101 in adults with Angelman syndrome and a Phase I trial in adolescents with Angelman syndrome or Fragile X syndrome. Ovid is also developing OV935 in collaboration with Takeda Pharmaceutical Company Limited for the treatment of rare epileptic encephalopathies.
Biopharmaceutical Organ Systems Disorders Neurological Disorders Epilepsy Genodermatoses Sedatives Anticonvulsants Fragile X Syndrome Syndromes
Is OVID a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.14
52 Week Low 1.53
Average Volume 588,284
200-Day Moving Average 2.2031
50-Day Moving Average 2.3278
20-Day Moving Average 2.7025
10-Day Moving Average 2.331
Average True Range 0.2388
ADX 25.77
+DI 26.099
-DI 23.1683
Chandelier Exit (Long, 3 ATRs ) 3.2536
Chandelier Exit (Short, 3 ATRs ) 2.8064
Upper Bollinger Band 3.6016
Lower Bollinger Band 1.8034
Percent B (%b) 0.28
BandWidth 66.53839
MACD Line -0.0389
MACD Signal Line 0.0252
MACD Histogram -0.0641
Fundamentals Value
Market Cap 56.83 Million
Num Shares 24.6 Million
EPS -4.85
Price-to-Earnings (P/E) Ratio -0.48
Price-to-Sales 0.00
Price-to-Book 1.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.52
Resistance 3 (R3) 2.54 2.49 2.49
Resistance 2 (R2) 2.49 2.44 2.48 2.47
Resistance 1 (R1) 2.40 2.40 2.38 2.38 2.46
Pivot Point 2.35 2.35 2.34 2.34 2.35
Support 1 (S1) 2.26 2.30 2.24 2.24 2.16
Support 2 (S2) 2.21 2.26 2.20 2.15
Support 3 (S3) 2.12 2.21 2.14
Support 4 (S4) 2.10